Your browser doesn't support javascript.
loading
Chimeric mRNA-based COVID-19 vaccine induces protective immunity against Omicron and Delta variants.
Hu, Qidong; Zhao, Ying; Shaabani, Namir; Lyu, Xiaoxuan; Powers, Colin; Sun, Haotian; Cruz, Vincent; Stegman, Karen; Xu, Jia; Fossier, Amber; Huang, Yu; Ho, Giang; Kao, Yi; Wang, Zhihao; Wang, Zhenping; Hu, Yue; Zheng, Yi; Kyaw, Lilian; Zuluaga, Cipriano; Wang, Hua; Pei, Hong; Allen, Robert; Xie, Hui; Ji, Henry; Chen, Runqiang.
Afiliação
  • Hu Q; Sorrento Therapeutics Inc., 4955 Directors Place, San Diego, CA 92121, USA.
  • Zhao Y; Sorrento Therapeutics Inc., 4955 Directors Place, San Diego, CA 92121, USA.
  • Shaabani N; Sorrento Therapeutics Inc., 4955 Directors Place, San Diego, CA 92121, USA.
  • Lyu X; Sorrento Therapeutics Inc., 4955 Directors Place, San Diego, CA 92121, USA.
  • Powers C; Sorrento Therapeutics Inc., 4955 Directors Place, San Diego, CA 92121, USA.
  • Sun H; Sorrento Therapeutics Inc., 4955 Directors Place, San Diego, CA 92121, USA.
  • Cruz V; Sorrento Therapeutics Inc., 4955 Directors Place, San Diego, CA 92121, USA.
  • Stegman K; Sorrento Therapeutics Inc., 4955 Directors Place, San Diego, CA 92121, USA.
  • Xu J; Sorrento Therapeutics Inc., 4955 Directors Place, San Diego, CA 92121, USA.
  • Fossier A; Sorrento Therapeutics Inc., 4955 Directors Place, San Diego, CA 92121, USA.
  • Huang Y; Sorrento Therapeutics Inc., 4955 Directors Place, San Diego, CA 92121, USA.
  • Ho G; Sorrento Therapeutics Inc., 4955 Directors Place, San Diego, CA 92121, USA.
  • Kao Y; Sorrento Therapeutics Inc., 4955 Directors Place, San Diego, CA 92121, USA.
  • Wang Z; Sorrento Therapeutics Inc., 4955 Directors Place, San Diego, CA 92121, USA.
  • Wang Z; Sorrento Therapeutics Inc., 4955 Directors Place, San Diego, CA 92121, USA.
  • Hu Y; Sorrento Therapeutics Inc., 4955 Directors Place, San Diego, CA 92121, USA.
  • Zheng Y; Sorrento Therapeutics Inc., 4955 Directors Place, San Diego, CA 92121, USA.
  • Kyaw L; Sorrento Therapeutics Inc., 4955 Directors Place, San Diego, CA 92121, USA.
  • Zuluaga C; Sorrento Therapeutics Inc., 4955 Directors Place, San Diego, CA 92121, USA.
  • Wang H; Sorrento Therapeutics Inc., 4955 Directors Place, San Diego, CA 92121, USA.
  • Pei H; Sorrento Therapeutics Inc., 4955 Directors Place, San Diego, CA 92121, USA.
  • Allen R; Sorrento Therapeutics Inc., 4955 Directors Place, San Diego, CA 92121, USA.
  • Xie H; Sorrento Therapeutics Inc., 4955 Directors Place, San Diego, CA 92121, USA.
  • Ji H; Sorrento Therapeutics Inc., 4955 Directors Place, San Diego, CA 92121, USA.
  • Chen R; Sorrento Therapeutics Inc., 4955 Directors Place, San Diego, CA 92121, USA.
Mol Ther Nucleic Acids ; 30: 465-476, 2022 Dec 13.
Article em En | MEDLINE | ID: mdl-36345542
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Mol Ther Nucleic Acids Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Mol Ther Nucleic Acids Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos